| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VETIMM.2009.11.001 |
| P698 | PubMed publication ID | 19959244 |
| P2093 | author name string | Guang-Zhi Tong | |
| Akio Nakane | |||
| Dong-Liang Hu | |||
| Jing-Chun Cui | |||
| Ai-Dong Qian | |||
| Bao-Jun Zhang | |||
| Quan-Kai Wang | |||
| Yan-Chun Lin | |||
| P2860 | cites work | Crystal structure of a T-cell receptor beta-chain complexed with a superantigen | Q27733857 |
| A mutant of staphylococcal enterotoxin C devoid of bacterial superantigenic activity elicits a Th2 immune response for protection against Staphylococcus aureus infection | Q33558510 | ||
| Characterization of a putative pathogenicity island from bovine Staphylococcus aureus encoding multiple superantigens | Q33995165 | ||
| Pathogenic Mechanisms of Enterococcal Endocarditis | Q34092264 | ||
| Superantigens: microbial agents that corrupt immunity | Q34123105 | ||
| Toxic shock syndrome and bacterial superantigens: an update | Q34360764 | ||
| Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses. | Q34391170 | ||
| Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice | Q35397535 | ||
| The economic implications of bioengineered mastitis control | Q35985450 | ||
| The pathogenesis and control of Staphylococcus aureus-induced mastitis: study models in the mouse | Q36074914 | ||
| A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor beta chain and major histocompatibility complex class II. | Q36400491 | ||
| Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death | Q37383159 | ||
| Protective effects of recombinant staphylococcal enterotoxin type C mutant vaccine against experimental bovine infection by a strain of Staphylococcus aureus isolated from subclinical mastitis in dairy cattle | Q38501524 | ||
| Pyrogenic toxin superantigen site specificity in toxic shock syndrome and food poisoning in animals | Q39516496 | ||
| Protection against bacterial superantigen staphylococcal enterotoxin B by passive vaccination | Q39654857 | ||
| Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model. | Q39821625 | ||
| Virulence factors involved in the pathogenesis of bovine intramammary infections due to Staphylococcus aureus | Q40714145 | ||
| The prospects for developing a vaccine against Staphylococcus aureus | Q40944595 | ||
| Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1. | Q42650682 | ||
| Intranasal immunization of mutant toxic shock syndrome toxin 1 elicits systemic and mucosal immune response against Staphylococcus aureus infection | Q44195603 | ||
| Comparative prevalence of superantigenic toxin genes in meticillin-resistant and meticillin-susceptible Staphylococcus aureus isolates | Q45196150 | ||
| Staphylococcal vaccines | Q47568588 | ||
| Double mutant and formaldehyde inactivated TSST-1 as vaccine candidates for TSST-1-induced toxic shock syndrome. | Q54551509 | ||
| Association between phage types and antimicrobial resistance among bovine Staphylococcus aureus from 10 countries | Q59149396 | ||
| Exotoxins of Staphylococcus aureus | Q64684334 | ||
| Superantigen vaccines: a comparative study of genetically attenuated receptor-binding mutants of staphylococcal enterotoxin A | Q71237042 | ||
| Staphylococcal enterotoxin B mutants (N23K and F44S): biological effects and vaccine potential in a mouse model | Q73145886 | ||
| Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection | Q73839685 | ||
| Bovine mastitis pathogens in New York and Pennsylvania: prevalence and effects on somatic cell count and milk production | Q73854341 | ||
| Epidemiologic study of intramammary infections with Staphylococcus aureus during a control program in nine commercial dairy herds | Q73909198 | ||
| Differential immune responses to staphylococcal enterotoxin B mutations in a hydrophobic loop dominating the interface with major histocompatibility complex class II receptors | Q74422418 | ||
| Development of engineered vaccines effective against structurally related bacterial superantigens | Q77487098 | ||
| Comprehensive analysis of classical and newly described staphylococcal superantigenic toxin genes in Staphylococcus aureus isolates | Q81756255 | ||
| Characteristics and epidemiologic genotyping of Staphylococcus aureus isolates from bovine mastitic milk in Hokkaido, Japan | Q82745723 | ||
| P433 | issue | 1-2 | |
| P921 | main subject | Staphylococcus aureus | Q188121 |
| P304 | page(s) | 64-70 | |
| P577 | publication date | 2009-11-11 | |
| P1433 | published in | Veterinary Immunology and Immunopathology | Q7923704 |
| P1476 | title | Protective effect of glutathione S-transferase-fused mutant staphylococcal enterotoxin C against Staphylococcus aureus-induced bovine mastitis | |
| P478 | volume | 135 |
| Q40550051 | Genotyping of Staphylococcus aureus in bovine mastitis and correlation to phenotypic characteristics |
| Q35963399 | Protective effect of recombinant staphylococcal enterotoxin A entrapped in polylactic-co-glycolic acid microspheres against Staphylococcus aureus infection |
| Q64072576 | Staphylococcal Enterotoxin C Is an Important Virulence Factor for Mastitis |
Search more.